Cost-effectiveness of screening for hepatitis C in Canada

BACKGROUND: The seroprevalence of hepatitis C virus (HCV) infection among Canadians is estimated at 0.3% to 0.9%. Of those with chronic HCV infection, 10% to 20% will experience advanced liver disease by 30 years of infection. Targeted screening seems a plausible strategy. We aimed to estimate the h...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:CMAJ
Main Authors: Wong, William W.L., Tu, Hong-Anh, Feld, Jordan J., Wong, Tom, Krahn, Murray
Format: Artigo
Sprog:Inglês
Udgivet: 8872147 Canada Inc. 2015
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4330166/
https://ncbi.nlm.nih.gov/pubmed/25583667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.140711
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker